When the pancreas stops producing insulin, glucose doesn't enter our cells. Instead, it accumulates in the bloodstream. In ...

NICE recommends SGLT-2 inhibitors with metformin at diagnosis, citing major cardiovascular, renal, and mortality benefits.

A deep molecular analysis of failing human hearts suggests diabetes may directly alter cardiac metabolism, but experts differ ...

Can advances in technology help stop chronic diseases before they start? The authors of a new perspective article argue that by identifying ‘biological drifts’ in each person, scientists may be able ...

Lantidra therapy infuses healthy islet cells into patients' livers, with some achieving insulin independence. University ...

New dedicated spaces offer condition-specific education, peer support, and meaningful engagement opportunities for ...

A large six-year clinical trial suggests that combining a Mediterranean-style diet with exercise and behavioral support may ...

A North Texas man's life was saved after a massive "widowmaker" heart attack at just 26 — quick CPR and surgery gave him a ...

Doctors should prescribe a sodium-glucose cotransporter-2 (SGLT-2) inhibitor alongside metformin to most patients with newly diagnosed type 2 diabetes, the National Institute for Health and Care ...

At-home technology for diabetes continues to evolve, giving people more peace of mind that the disease is in check while they ...

Today, the American Diabetes Association(R) (ADA) announced the awardees of the 2026 Pathway to Stop Diabetes(R) (Pathway) Award grants. The seven new awards, totaling $11.3 million in strategic ...

Portal Diabetes has received Breakthrough Device Designation by the Food and Drug Administration (FDA) for its implantable ...